Proceedings of 25th Annual General Meeting of the Company held on July 23, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Windlas Biotech Limited Reg. Off.: 40/1, Mohabewala Industrial Area Dehradun, Uttarakhand 248 110, India Tel.:+91-135-6608000-30, Fax:+91-135-6608199 Corp. Off.: 705-706, Vatika Professional Point, Sector-66, Golf Course Ext. Road, Gurgaon, Haryana 122 001, India Tel.:+91-124-2821030 CIN-L74899UR2001PLC033407 July 23, 2026 To To Listing / Compliance Department Listing / Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai – 400 001 Bandra Kurla Complex Bandra (E), Mumbai – 400 051 BSE CODE: 543329 NSE SYMBOL: WINDLAS Dear Sir/ Madam, Re: Proceedings of 25th Annual General Meeting of the Company held on July 23, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We are pleased to inform you that the 25th Annual General Meeting (AGM) of the Company was held on Thursday, July 23, 2026 at 01:00 P.M. through Video Conferencing (VC) in compliance with relevant Circulars issued by the Ministry of Corporate Affairs (MCA) and the Securities and Exchange Board of India (SEBI). 63 (Sixty Three) members attended the meeting. Mr. Vivek Dhariwal, Chairman took the Chair. He welcomed and introduced the Directors present in the meeting. All directors were present in the Meeting except Mr. Gaurav Gulati, Non-executive Independent Director. It was informed to the Members that Mr. Gaurav Gulati, Director of the Company, could not attend the Annual General Meeting due to prior commitments and had conveyed his regrets. The Members were further informed that Mr. Gaurav Gulati had authorized Mr. Hitesh Windlass, Managing Director, to represent him as Chairman of the Audit Committee and the Nomination and Remuneration Committee and respond to Members' queries relating to these Committees. Further, Mr. Manoj Kumar Windlass, Joint Managing Director and Member of the Stakeholders' Relationship Committee, was authorized to represent him as Chairman of the Stakeholders' Relationship Committee and respond to Members' queries relating to the Committee. The representatives of M/s J C Bhalla & Co., Statutory Auditors, M/s Sandeep Joshi & Associates, Secretarial Auditors, M/s Sourabh Jain & Associates, Cost Auditors and Mr. Sandeep Joshi, Company Secretary in Practice, scrutinizer for the e-Voting and the Voting during the proceedings of the AGM, were also present at the Meeting through Video Conferencing. The Registers as required under the Companies Act, 2013 and other relevant documents mentioned in the AGM Notice were available for inspection. The following items as set out in the Notice convening the 25th Annual General Meeting were transacted: www.windlas.com Windlas Biotech Limited Reg. Off.: 40/1, Mohabewala Industrial Area Dehradun, Uttarakhand 248 110, India Tel.:+91-135-6608000-30, Fax:+91-135-6608199 Corp. Off.: 705-706, Vatika Professional Point, Sector-66, Golf Course Ext. Road, Gurgaon, Haryana 122 001, India Tel.:+91-124-2821030 CIN-L74899UR2001PLC033407 Sl. No. Items/Resolution Type of Resolution 1 Adoption of the Audited Standalone and Consolidated Financial Statements of the Ordinary Resolution Company for the financial year ended March 31, 2026, together with the Reports of the Auditors and the Board of Directors’ thereon. 2 Declaration of final dividend of Rs. 6.30/- per Equity Share for the financial year Ordinary Resolution 2025-26. 3 Appointment of a Director in place of Mr. Hitesh Windlass, Managing Director Ordinary Resolution (DIN:02030941) who is liable to retire by rotation and being eligible, offers himself for re-appointment. 4 Appointment of a Director in place of Mrs. Prachi Jain Windlass, Director Ordinary Resolution (DIN:06661073) who is liable to retire by rotation and being eligible, offers himself for re-appointment. 5 Ratification of the remuneration of the Cost Auditor. Ordinary Resolution 6 Appointment of Dr. Tarashree Singhal (DIN:11697518) as an Independent Director. Special Resolution The Shareholders who had registered themselves as Speakers were invited to express their views/ raise questions. All queries of the Shareholders were satisfactorily replied by the Managing Director and the CEO&CFO of the Company. The voting on all the above resolutions was conducted through remote e-voting and e-voting at the AGM. The consolidated voting results along with the Scrutinizer’s Report would be placed on the Company’s website www.windlas.com, MUFG Intime website and would also be available on the websites of Stock Exchanges viz., BSE Limited and National Stock Exchange of India Limited, respectively, where the shares of the Company are listed. The AGM was deemed to have concluded at 02.05 p.m. (IST) post expiry of 15 minutes time allotted for the members to cast their vote. Thanking you, Yours faithfully, For Windlas Biotech Limited Ananta Narayan Panda Company Secretary & Compliance Officer www.windlas.com